Express Scripts, Medco Delay Deal Pending FTC Review
Express Scripts Inc. and Medco Health Solutions Inc. said Monday that they would postpone completing their merger to give antitrust regulators more time to review the pharmacy benefits managers' proposed $29...To view the full article, register now.
Already a subscriber? Click here to view full article